327 related articles for article (PubMed ID: 16947529)
1. Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
Fernandez D; Bonilla E; Mirza N; Niland B; Perl A
Arthritis Rheum; 2006 Sep; 54(9):2983-8. PubMed ID: 16947529
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.
Lai ZW; Kelly R; Winans T; Marchena I; Shadakshari A; Yu J; Dawood M; Garcia R; Tily H; Francis L; Faraone SV; Phillips PE; Perl A
Lancet; 2018 Mar; 391(10126):1186-1196. PubMed ID: 29551338
[TBL] [Abstract][Full Text] [Related]
3. Metabolic control of T cell activation and death in SLE.
Fernandez D; Perl A
Autoimmun Rev; 2009 Jan; 8(3):184-9. PubMed ID: 18722557
[TBL] [Abstract][Full Text] [Related]
4. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.
Fernandez DR; Telarico T; Bonilla E; Li Q; Banerjee S; Middleton FA; Phillips PE; Crow MK; Oess S; Muller-Esterl W; Perl A
J Immunol; 2009 Feb; 182(4):2063-73. PubMed ID: 19201859
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
Lai ZW; Hanczko R; Bonilla E; Caza TN; Clair B; Bartos A; Miklossy G; Jimah J; Doherty E; Tily H; Francis L; Garcia R; Dawood M; Yu J; Ramos I; Coman I; Faraone SV; Phillips PE; Perl A
Arthritis Rheum; 2012 Sep; 64(9):2937-46. PubMed ID: 22549432
[TBL] [Abstract][Full Text] [Related]
6. Signaling abnormalities in systemic lupus erythematosus as potential drug targets.
Fernandez D; Bonilla E; Phillips P; Perl A
Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):305-11. PubMed ID: 17214576
[TBL] [Abstract][Full Text] [Related]
7. Restoring T-helper 17 cell/regulatory T-cell balance and decreasing disease activity by rapamycin and all-trans retinoic acid in patients with systemic lupus erythematosus.
Chu Y; Zhao C; Zhang B; Wang X; Wang Y; An J; Chen J
Lupus; 2019 Oct; 28(12):1397-1406. PubMed ID: 31551029
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus.
Lai ZW; Borsuk R; Shadakshari A; Yu J; Dawood M; Garcia R; Francis L; Tily H; Bartos A; Faraone SV; Phillips P; Perl A
J Immunol; 2013 Sep; 191(5):2236-46. PubMed ID: 23913957
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells.
Nagy G; Barcza M; Gonchoroff N; Phillips PE; Perl A
J Immunol; 2004 Sep; 173(6):3676-83. PubMed ID: 15356113
[TBL] [Abstract][Full Text] [Related]
11. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
[TBL] [Abstract][Full Text] [Related]
12. Calcium signaling in systemic lupus erythematosus T cells: a treatment target.
Kyttaris VC; Zhang Z; Kampagianni O; Tsokos GC
Arthritis Rheum; 2011 Jul; 63(7):2058-66. PubMed ID: 21437870
[TBL] [Abstract][Full Text] [Related]
13. T-cell and B-cell signaling biomarkers and treatment targets in lupus.
Perl A; Fernandez DR; Telarico T; Doherty E; Francis L; Phillips PE
Curr Opin Rheumatol; 2009 Sep; 21(5):454-64. PubMed ID: 19550330
[TBL] [Abstract][Full Text] [Related]
14. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
Wei S; Yoshida N; Finn G; Kozono S; Nechama M; Kyttaris VC; Zhen Zhou X; Tsokos GC; Ping Lu K
Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
[TBL] [Abstract][Full Text] [Related]
15. Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: A subgroup analysis from a phase 3 randomized placebo-controlled trial.
Tanaka Y; Bass D; Chu M; Egginton S; Ji B; Roth D
Mod Rheumatol; 2020 Mar; 30(2):313-320. PubMed ID: 31199180
[No Abstract] [Full Text] [Related]
16. Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil.
Zahr N; Arnaud L; Marquet P; Haroche J; Costedoat-Chalumeau N; Hulot JS; Funck-Brentano C; Piette JC; Amoura Z
Arthritis Rheum; 2010 Jul; 62(7):2047-54. PubMed ID: 20506558
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.
Portales-Pérez D; González-Amaro R; Abud-Mendoza C; Sánchez-Armáss S
Lupus; 1997; 6(1):48-56. PubMed ID: 9116719
[TBL] [Abstract][Full Text] [Related]
18. HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.
Caza TN; Fernandez DR; Talaber G; Oaks Z; Haas M; Madaio MP; Lai ZW; Miklossy G; Singh RR; Chudakov DM; Malorni W; Middleton F; Banki K; Perl A
Ann Rheum Dis; 2014 Oct; 73(10):1888-97. PubMed ID: 23897774
[TBL] [Abstract][Full Text] [Related]
19. The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus.
Nagy G; Perl A
Clin Immunol; 2006; 118(2-3):145-51. PubMed ID: 16406340
[TBL] [Abstract][Full Text] [Related]
20. Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus.
Perl A; Hanczko R; Doherty E
Methods Mol Biol; 2012; 900():61-89. PubMed ID: 22933065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
